Zhi-Qing Liu (Zhiqing Liu)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Journal of medicinal chemistry

Marine drugs

University of Texas Medical Branch at Galveston

Shanghai Institute of Materia Medica Chinese Academy of Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas Medical Branch at Galveston Jun 16 2014

United States

Postdoctoral Fellow :: Department of Pharmacology and Toxicology

Education History

Shanghai Institute of Materia Medica Chinese Academy of Sciences Sep 01 2009 - Jun 15 2014

China

PHD

Publications

Yue Zhou, Na He, Qian Liu, Rui Li, Lujia Yang, Wei Kang, Xinxin Zhang, Xiaoyu Xu, Guangshan Yao, Pingyuan Wang, Chang-Yun Wang, Jinbo Yang, Zhi-Qing Liu
Structural Optimization of Marine Natural Product Pretrichodermamide B for the Treatment of Colon Cancer by Targeting the JAK/STAT3 Signaling Pathway. Journal of medicinal chemistry 67 (13) (2024)
Yue Zhou, Na He, Qian Liu, Rui Li, Lujia Yang, Wei Kang, Xinxin Zhang, Xiaoyu Xu, Guangshan Yao, Pingyuan Wang, Chang-Yun Wang, Jinbo Yang, Zhi-Qing Liu
Structural Optimization of Marine Natural Product Pretrichodermamide B for the Treatment of Colon Cancer by Targeting the JAK/STAT3 Signaling Pathway. Journal of medicinal chemistry 67 (13) (2024)
Yue Zhou, Na He, Qian Liu, Rui Li, Lujia Yang, Wei Kang, Xinxin Zhang, Xiaoyu Xu, Guangshan Yao, Pingyuan Wang, Chang-Yun Wang, Jinbo Yang, Zhi-Qing Liu
Structural Optimization of Marine Natural Product Pretrichodermamide B for the Treatment of Colon Cancer by Targeting the JAK/STAT3 Signaling Pathway. Journal of medicinal chemistry (2024)
Yue Zhou, Na He, Qian Liu, Rui Li, Lujia Yang, Wei Kang, Xinxin Zhang, Xiaoyu Xu, Guangshan Yao, Pingyuan Wang, Chang-Yun Wang, Jinbo Yang, Zhi-Qing Liu
Structural Optimization of Marine Natural Product Pretrichodermamide B for the Treatment of Colon Cancer by Targeting the JAK/STAT3 Signaling Pathway. Journal of medicinal chemistry 67 (13) (2024)
Zongbo Feng, Chunju Yang, Yi Zhang, Huaxuan Li, Wei Fang, Junhua Wang, Yichu Nie, Chang-Yun Wang, Zhi-Qing Liu, Zhimin Jiang, Junjian Wang, Yuanxiang Wang
Structure-Based Design and Characterization of the Highly Potent and Selective Covalent Inhibitors Targeting the Lysine Methyltransferases G9a/GLP. Journal of medicinal chemistry (2023)
Mireguli Maimaitiming, Ling Lv, Xuetao Zhang, Shuli Xia, Xin Li, Pingyuan Wang, Zhi-Qing Liu, Chang-Yun Wang
Semi-Synthesis and Biological Evaluation of 25( R) -26-Acetoxy-3 β ,5 α -Dihydroxycholest-6-One. Marine drugs 21 (3) (2023)
Mireguli Maimaitiming, Ling Lv, Xuetao Zhang, Shuli Xia, Xin Li, Pingyuan Wang, Zhi-Qing Liu, Chang-Yun Wang
Semi-Synthesis and Biological Evaluation of 25( R) -26-Acetoxy-3 β ,5 α -Dihydroxycholest-6-One. Marine drugs 21 (3) (2023)
Mireguli Maimaitiming, Ling Lv, Xuetao Zhang, Shuli Xia, Xin Li, Pingyuan Wang, Zhi-Qing Liu, Chang-Yun Wang
Semi-Synthesis and Biological Evaluation of 25( R) -26-Acetoxy-3 β ,5 α -Dihydroxycholest-6-One. Marine drugs 21 (3) (2023)
Mireguli Maimaitiming, Ling Lv, Xuetao Zhang, Shuli Xia, Xin Li, Pingyuan Wang, Zhi-Qing Liu, Chang-Yun Wang
Semi-Synthesis and Biological Evaluation of 25( R) -26-Acetoxy-3 β ,5 α -Dihydroxycholest-6-One. Marine drugs 21 (3) (2023)
Zhi-Qing Liu, Yi Li, Haiying Chen, Hsien-Tsung Lai, Pingyuan Wang, Shwu-Yuan Wu, Eric A Wold, Paul G Leonard, Sarah Joseph, Haitao Hu, Cheng-Ming Chiang, Allan R Brasier, Bing Tian, Jia Zhou
Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site. Journal of medicinal chemistry 65 (3) (2022)
Haoran Li, Mireguli Maimaitiming, Yue Zhou, Huaxuan Li, Pingyuan Wang, Yang Liu, Till F Schäberle, Zhi-Qing Liu, Chang-Yun Wang
Discovery of Marine Natural Products as Promising Antibiotics against Pseudomonas aeruginosa . Marine drugs 20 (3) (2022)
Zhi-Qing Liu, Pingyuan Wang, Eric A Wold, Qiaoling Song, Chenyang Zhao, Chang-Yun Wang, Jia Zhou
Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer. Journal of medicinal chemistry 64 (8) (2021)
Pingyuan Wang, Paul A Wadsworth, Nolan M Dvorak, Aditya K Singh, Haiying Chen, Zhi-Qing Liu, Richard Zhou, Luis Marcelo F Holthauzen, Jia Zhou, Fernanda Laezza
Design, Synthesis, and Pharmacological Evaluation of Analogues Derived from the PLEV Tetrapeptide as Protein-Protein Interaction Modulators of Voltage-Gated Sodium Channel 1.6. Journal of medicinal chemistry 63 (20) (2020)
Pingyuan Wang, Urszula Luchowska-Stańska, Boy van Basten, Haiying Chen, Zhi-Qing Liu, Jolanta Wiejak, Padraic Whelan, David Morgan, Emma Lochhead, Graeme Barker, Holger Rehmann, Stephen J Yarwood, Jia Zhou
Synthesis and Biochemical Evaluation of Noncyclic Nucleotide Exchange Proteins Directly Activated by cAMP 1 (EPAC1) Regulators. Journal of medicinal chemistry 63 (10) (2020)
Lu-Jia Yang, Xiao-Yue Peng, Ya-Hui Zhang, Zhi-Qing Liu, Xin Li, Yu-Cheng Gu, Chang-Lun Shao, Zhuang Han, Chang-Yun Wang
Antimicrobial and Antioxidant Polyketides from a Deep-Sea-Derived Fungus Aspergillus versicolor SH0105. Marine drugs 18 (12) (2020)
Zhi-Qing Liu, Haiying Chen, Pingyuan Wang, Yi Li, Eric A Wold, Paul G Leonard, Sarah Joseph, Allan R Brasier, Bing Tian, Jia Zhou
Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation. Journal of medicinal chemistry 63 (10) (2020)

Zhi-Qing Liu.css-eqlu8i{font-size:small;padding-left:4px;} (Zhiqing Liu)

Publication Activity (10 Years)

Top Topics

Top Venues

Zhi-Qing Liu (Zhiqing Liu)